Nautilus Biotechnology, Inc. NAUT
Institutional shares held
63.2 Million
158K
calls
0
puts
Total value of holdings
$42.4M
$105K
calls
$0
puts
Market Cap
$81M
124,663,000
Shares Out.
Institutional ownership
50.71%
# of Institutions
75
We take great care to ensure that the data presented and summarized in this overview for Nautilus Biotechnology, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding NAUT
View all-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA16.3MShares$10.6 Million24.08% of portfolio
-
Perceptive Advisors LLC New York, NY12.6MShares$8.19 Million0.4% of portfolio
-
Cercano Management LLC Bellevue, WA7.17MShares$4.66 Million0.16% of portfolio
-
Madrona Venture Group, LLC6.02MShares$3.91 Million34.58% of portfolio
-
Black Rock Inc. New York, NY3.83MShares$2.49 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.49MShares$1.62 Million0.0% of portfolio
-
Comprehensive Financial Management LLC Los Gatos, CA2.21MShares$1.43 Million0.04% of portfolio
-
Amazon Com Inc1.46MShares$947,0850.04% of portfolio
-
Ah Equity Partners Lsv Ii, L.L.C. Menlo Park, CA1.36MShares$881,3424.48% of portfolio
-
Clarius Group, LLC Seattle, WA1.06MShares$689,2990.05% of portfolio
Latest Institutional Activity in NAUT
Top Purchases
Top Sells
About NAUT
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
Insider Transactions at NAUT
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 29
2025
|
Anna Mowry CFO and Treasurer |
BUY
Open market or private purchase
|
Direct |
15,000
+15.31%
|
$0
$0.77 P/Share
|
|
May 12
2025
|
Parag Mallick Chief Scientist |
BUY
Open market or private purchase
|
Direct |
1,500
+0.01%
|
$0
$0.73 P/Share
|
|
May 08
2025
|
Parag Mallick Chief Scientist |
BUY
Open market or private purchase
|
Direct |
12,000
+0.06%
|
$0
$0.73 P/Share
|
|
Mar 20
2025
|
Sujal M Patel CEO, President, and Secretary |
BUY
Open market or private purchase
|
Direct |
23,933
+0.24%
|
$23,933
$1.0 P/Share
|
|
Mar 19
2025
|
Sujal M Patel CEO, President, and Secretary |
BUY
Open market or private purchase
|
Direct |
53,300
+0.52%
|
$0
$0.99 P/Share
|
|
Sep 23
2024
|
Mary E. Godwin Senior VP, Operations |
SELL
Open market or private sale
|
Direct |
47,031
-100.0%
|
$94,062
$2.87 P/Share
|
|
Sep 23
2024
|
Mary E. Godwin Senior VP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
47,031
+50.0%
|
$0
$0.46 P/Share
|
|
Sep 17
2024
|
Mary E. Godwin Senior VP, Operations |
SELL
Open market or private sale
|
Direct |
35,000
-100.0%
|
$70,000
$2.85 P/Share
|
|
Sep 17
2024
|
Mary E. Godwin Senior VP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+50.0%
|
$0
$0.46 P/Share
|
|
Mar 11
2024
|
Sujal M Patel CEO, President, and Secretary |
BUY
Open market or private purchase
|
Direct |
12,044
+0.12%
|
$24,088
$2.84 P/Share
|
|
Mar 08
2024
|
Sujal M Patel CEO, President, and Secretary |
BUY
Open market or private purchase
|
Direct |
2,430
+0.02%
|
$4,860
$2.99 P/Share
|
|
Mar 07
2024
|
Sujal M Patel CEO, President, and Secretary |
BUY
Open market or private purchase
|
Direct |
18,854
+0.19%
|
$37,708
$2.89 P/Share
|
|
Mar 06
2024
|
Sujal M Patel CEO, President, and Secretary |
BUY
Open market or private purchase
|
Direct |
9,267
+0.09%
|
$18,534
$2.7 P/Share
|
|
Mar 05
2024
|
Sujal M Patel CEO, President, and Secretary |
BUY
Open market or private purchase
|
Direct |
7,405
+0.07%
|
$14,810
$2.65 P/Share
|
|
Sep 27
2022
|
Subramanian Sankar Senior VP, Product Development |
BUY
Open market or private purchase
|
Direct |
5,000
+5.19%
|
$10,000
$2.03 P/Share
|
|
Sep 26
2022
|
Subramanian Sankar Senior VP, Product Development |
BUY
Open market or private purchase
|
Direct |
10,000
+10.39%
|
$20,000
$2.02 P/Share
|
|
Sep 23
2022
|
Gwen E Weld Chief People Officer |
BUY
Open market or private purchase
|
Direct |
30,000
+50.0%
|
$60,000
$2.03 P/Share
|
|
Sep 16
2022
|
Subramanian Sankar Senior VP, Product Development |
BUY
Open market or private purchase
|
Direct |
35,000
+31.82%
|
$70,000
$2.16 P/Share
|
|
Sep 15
2022
|
Subramanian Sankar Senior VP, Product Development |
BUY
Open market or private purchase
|
Direct |
40,000
+50.0%
|
$80,000
$2.19 P/Share
|
|
Aug 19
2022
|
Anna Mowry CFO and Treasurer |
BUY
Open market or private purchase
|
Direct |
17,500
+23.57%
|
$35,000
$2.3 P/Share
|
Last 12 Months Summary
Buy / Acquisition
188K
Shares
From
4
Insiders
| Exercise of conversion of derivative security | 82K shares |
|---|---|
| Open market or private purchase | 106K shares |
Sell / Disposition
82K
Shares
From
1
Insiders
| Open market or private sale | 82K shares |
|---|